Fighting malaria in Madhya Pradesh (Central India): are we losing the battle?
Malaria control in Madhya Pradesh is complex because of vast tracts of forest with tribal settlement. Fifty four million individuals of various ethnic origins, accounting for 8% of the total population of India, contributed 30% of total malaria cases, 60% of total falciparum cases and 50% of malaria deaths in the country. Ambitious goals to control tribal malaria by launching "Enhanced Malaria Control Project" (EMCP) by the National Vector Borne Disease Control Programme (NVBDCP), with the World Bank assistance, became effective in September 1997 in eight north Indian states. Under EMCP, the programme used a broader mix of new interventions, i.e. insecticide-treated bed nets, spraying houses with effective residual insecticides, use of larvivorous fishes, rapid diagnostic tests for prompt diagnosis, treatment of the sick with effective radical treatment and increased public awareness and IEC. However, the challenge is to scale up these services.A retrospective analysis of data on malaria morbidity and associated mortality reported under the existing surveillance system of the Madhya Pradesh (Central India) for the years 1996-2007 was carried out to determine the impact of EMCP on malaria morbidity and associated mortality. Analysis revealed that despite the availability of effective intervention tools for the prevention and control of malaria, falciparum malaria remains uncontrolled and deaths due to malaria have increased. Precisely, the aim of this epidemiological analysis is to draw lessons applicable to all international aid efforts, bureaucracy, policy makers and programme managers in assessing its project performance as a new Global Malaria Action Plan is launched with ambitious goal of reducing malaria and its elimination by scaling up the use of existing tools.
Regional Medical Research Centre for Tribals and National Institute of Malaria Research Field Station Jabalpur 482003, Madhya Pradesh, India. neeru.singh@gmail.com
Neeru
N
Singh
Aditya P
AP
Dash
Krongthong
K
Thimasarn
D000818:Animals; D000852:Anopheles; D000962:Antimalarials / Q000627:therapeutic use; D003695:Delivery of Health Care; D004351:Drug Resistance; D006291:Health Policy; D006801:Humans; D015994:Incidence; D007194:India / Q000453:epidemiology; D007303:Insect Vectors / Q000187:drug effects; D007305:Insecticide Resistance; D008288:Malaria / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D009032:Mosquito Control / Q000379:methods*; D010963:Plasmodium falciparum; D010966:Plasmodium vivax; D011159:Population Surveillance / Q000379:methods; D012307:Risk Factors
D000962:Antimalarials